Monarch Medical Technologies has been driving innovation in insulin management technology for over 20 years. Since 2003, the company has focused on empowering nurses with a simplified insulin management process and supporting hospitals in enhancing patient safety through advanced technology.

Our vision is a world where every inpatient insulin dose is the right one. Our mission is to better the lives of hospital personnel and their patients by delivering safe and simple personalized insulin therapy, enabled by technology.

We prioritize people first, acting with empathy and putting people at the heart of every decision. We stay true to our word and purpose, think big to create a bright future, and strive to keep healthcare simple despite its complexity.

Our clinical advisory board consists of experienced physicians in endocrinology, pulmonology, and medical research, providing over 190 years of combined expertise. Monarch Medical Technologies is led by a seasoned healthcare executive team with extensive experience in medical technology and healthcare IT.

Founded as MD Scientific in 2003, the company developed the EndoTool glucose management system. Key milestones include FDA clearances, acquisitions, and the launch of patented technology that sets safety standards in glucose management. Monarch Medical Technologies continues to innovate and support healthcare systems nationwide.

Monarch Medical Technologies is committed to innovation and improving patient care. We invite individuals passionate about shaping healthcare's future to explore career opportunities at our company.

For inquiries, partnerships, or to learn more about our solutions, please visit our Contact Us page or request a tour. Follow us on LinkedIn, Twitter, and Facebook for updates and insights.